Lyell Immunopharma, Inc. (LYEL) has a market capitalization of $544.69M and trades at $23.37. The 52-week range is 7.65-45.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.5, Earnings Per Share (EPS) of $-16.06, annual revenue of $36K.
The stock has a beta of -0.07, operates in the Healthcare sector.
